Eli Lilly Reports Obesity Pill Sustains Weight Loss After Switching from Wegovy, Zepbound
The pharmaceutical company says its new treatment maintained weight loss in patients transitioning from existing obesity drugs, indicating potential for broader use.
Summary
No Summary provided as the original text is short
Terms & Concepts
Wegovy: A prescription weight-loss medication containing semaglutide, used to help manage obesity.
Zepbound: An Eli Lilly prescription drug for weight management, containing tirzepatide.
Obesity pill: An oral medication designed to aid weight loss and maintain results in patients with obesity.